<?xml version='1.0' encoding='iso-8859-1'?>
<PASBIO>
    <framesest>
        <predicate lemma="generate">
            <roleset id="generate.01" name="" wordnet="1">
                <roles>
                    <role n="0" descr="agent, causer&#09;&#09;//gene, process//&#10;" />
                    <role n="1" descr="thing created&#09;&#09;&#10;" />
                </roles>
                <example src="EGRAM" no="0">
					<text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and a 3863 bases RNA chain that occurs in the non-translated region 5 generated mature hela cell mRNA.</text>
					<arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
					<arg n="1">mature hela cell mRNA</arg>
				</example>
				<example src="EGRAM" no="0">
					<text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a 3863-base RNA fragment that occurs in the 5-untranslated region generated HeLa mature cell mRNA.</text>
					<arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
					<arg n="1">HeLa mature cell mRNA</arg>
				</example>
				<example src="EGRAM" no="1">
					<text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells.</text>
					<arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
					<arg n="1">mRNA of mature HeLa cells</arg>
				</example>
				<example src="EGRAM" no="1">
					<text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA.</text>
					<arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
					<arg n="1">HeLa mature cell mRNA</arg>
				</example>
				<example src="EGRAM" no="2">
					<text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and mature heLa cell mRNA has been generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
					<arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
					<arg n="1">mature heLa cell mRNA</arg>
				</example>
				<example src="EGRAM" no="2">
					<text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and matur HeLa cell mRNA was generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
					<arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
					<arg n="1">matur HeLa cell mRNA</arg>
				</example>
				<example src="EGRAM" no="3">
					<text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and mRNA of heLa cells is generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
					<arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
					<arg n="1">mRNA of heLa cells</arg>
				</example>
				<example src="EGRAM" no="3">
					<text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and matur HeLa cell mRNA is generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
					<arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
					<arg n="1">matur HeLa cell mRNA</arg>
				</example>
				<example src="EGRAM" no="4">
					<text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mRNA of heLa cells was generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
					<arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
					<arg n="1">mRNA of heLa cells</arg>
				</example>
				<example src="EGRAM" no="4">
					<text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and matur HeLa cell mRNA was generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
					<arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
					<arg n="1">matur HeLa cell mRNA</arg>
				</example>
				<example src="EGRAM" no="5">
					<text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mRNA of heLa cells will be generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
					<arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
					<arg n="1">mRNA of heLa cells</arg>
				</example>
				<example src="EGRAM" no="5">
					<text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and matur HeLa cell mRNA will be generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
					<arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
					<arg n="1">matur HeLa cell mRNA</arg>
				</example>
				<example src="EGRAM" no="6">
					<text>peptides abeta can be generated from A0 (amyloid precursor protein proteolysis (APP) by beta and gamma-secretases.</text>
					<arg n="1">peptides abeta</arg>
				</example>
				<example src="EGRAM" no="6">
					<text>abeta peptides can be generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
					<arg n="1">abeta peptides</arg>
				</example>
				<example src="EGRAM" no="7">
					<text>Abeta peptides was generated from A0 (amyloid precursor protein proteolysis (APP) by beta- and gamma-secretases.</text>
					<arg n="1">Abeta peptides</arg>
				</example>
				<example src="EGRAM" no="7">
					<text>abeta peptides have been generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
					<arg n="1">abeta peptides</arg>
				</example>
				<example src="EGRAM" no="8">
					<text>Abeta peptides was generated from A0 (amyloid precursor protein proteolysis (APP) by beta and gamma-secretases.</text>
					<arg n="1">Abeta peptides</arg>
				</example>
				<example src="EGRAM" no="8">
					<text>abeta peptides were generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
					<arg n="1">abeta peptides</arg>
				</example>
				<example src="EGRAM" no="9">
					<text>Although a crystal structure of RA is not available to date, it can be speculated that L723 in H3 has generated the correct three-dimensional interaction surface.</text>
					<arg n="0">L723 in H3</arg>
					<arg n="1">the correct three-dimensional interaction surface</arg>
				</example>
				<example src="EGRAM" no="9">
					<text>Although a crystalline structure of the RA is not available to date, it can be speculated that L723 in H3 has generated the correct three-dimensional interaction surface.</text>
					<arg n="0">L723 in H3</arg>
					<arg n="1">the correct three-dimensional interaction surface</arg>
				</example>
				<example src="EGRAM" no="10">
					<text>Although a crystal structure of RA is not available to date, it can be speculated that L723 in H3 generates the correct three-dimensional interaction surface.</text>
					<arg n="0">L723 in H3</arg>
					<arg n="1">the correct three-dimensional interaction surface</arg>
				</example>
				<example src="EGRAM" no="10">
					<text>Although a crystalline structure of the RA is not available to date, it can be speculated that L723 in H3 generates the correct three-dimensional interaction surface.</text>
					<arg n="0">L723 in H3</arg>
					<arg n="1">the correct three-dimensional interaction surface</arg>
				</example>
				<example src="EGRAM" no="11">
					<text>Although a crystal structure of RA is not available to date, it can be speculated that the correct three-dimensional interaction surface has been generated by L723 to H3.</text>
					<arg n="0">L723 to H3</arg>
					<arg n="1">the correct three-dimensional interaction surface</arg>
				</example>
				<example src="EGRAM" no="11">
					<text>Although a crystalline structure of the RA is not available to date, it can be speculated that the correct three-dimensional interaction surface has been generated by L723 in H3.</text>
					<arg n="0">L723 in H3</arg>
					<arg n="1">the correct three-dimensional interaction surface</arg>
				</example>
				<example src="EGRAM" no="12">
					<text>Although a crystal structure of RA is not available to date, it can be speculated that the correct three-dimensional interaction surface is generated by A0 (L723 in H3.</text>
					<arg n="1">the correct three-dimensional interaction surface</arg>
				</example>
				<example src="EGRAM" no="12">
					<text>Although a crystalline structure of the RA is not available to date, it can be speculated that the correct three-dimensional interaction surface is generated by A0 (L723 in H3.</text>
					<arg n="1">the correct three-dimensional interaction surface</arg>
				</example>
				<example src="EGRAM" no="13">
					<text>Although a crystal structure of RA is not available to date, it can be speculated that the correct three-dimensional interaction surface was generated by A0 (L723 in H3.</text>
					<arg n="1">the correct three-dimensional interaction surface</arg>
				</example>
				<example src="EGRAM" no="13">
					<text>Although a crystalline structure of the RA is not available to date, it can be speculated that the correct three-dimensional interaction surface was generated by A0 (L723 in H3.</text>
					<arg n="1">the correct three-dimensional interaction surface</arg>
				</example>
				<example src="EGRAM" no="14">
					<text>Although a crystal structure of RA is not available to date, it can be speculated that the correct three-dimensional interaction surface will be generated by A0 (L723 in H3.</text>
					<arg n="1">the correct three-dimensional interaction surface</arg>
				</example>
				<example src="EGRAM" no="14">
					<text>Although a crystalline structure of the RA is not available to date, it can be speculated that the correct three-dimensional interaction surface will be generated by A0 (L723 in H3.</text>
					<arg n="1">the correct three-dimensional interaction surface</arg>
				</example>
				<example src="EGRAM" no="15">
					<text>The HLA-G molecules of human leukocytes were generated by an alternative coupling of primary gene transcription and have demonstrated a specialized function in the regulation of the immune response.</text>
					<arg n="0">an alternative coupling of primary gene transcription</arg>
					<arg n="1">HLA</arg>
				</example>
				<example src="EGRAM" no="15">
					<text>The HLA-G molecules of human leukocytes have been generated by an alternative coupling of primary transcription of the gene and have shown a specialized function in regulating the immune response.</text>
					<arg n="0">an alternative coupling of primary transcription of the gene</arg>
					<arg n="1">HLA</arg>
				</example>
				<example src="EGRAM" no="16">
					<text>The HLA-G molecules of human leukocytes were generated by an alternative coupling of primary gene transcription and had a specialized function in regulating the immune response.</text>
					<arg n="0">an alternative coupling of primary gene transcription</arg>
					<arg n="1">HLA</arg>
				</example>
				<example src="EGRAM" no="16">
					<text>The HLA-G molecules of human leukocytes were generated by an alternative coupling of the primary transcription of the gene and showed a specialized function in regulating the immune response.</text>
					<arg n="0">an alternative coupling of the primary transcription of the gene</arg>
					<arg n="1">HLA</arg>
				</example>
				<example src="EGRAM" no="17">
					<text>HLA-G molecules) will be generated by an alternative splicing of primary gene transcription and will have a specialized function in regulating the immune response.</text>
					<arg n="0">an alternative splicing of primary gene transcription</arg>
					<arg n="1">HLA</arg>
				</example>
				<example src="EGRAM" no="17">
					<text>The HLA-G molecules are generated by an alternative coupling of the primary transcription of the gene and show a specialized function in regulating the immune response.</text>
					<arg n="0">an alternative coupling of the primary transcription of the gene</arg>
					<arg n="1">HLA</arg>
				</example>
				<example src="EGRAM" no="18">
					<text>In addition, the N-terminal RA generated a surface of functional interaction, since its suppression abolished FHL2 binding.</text>
					<arg n="0">the N-terminal RA</arg>
					<arg n="1">a surface of functional interaction</arg>
				</example>
				<example src="EGRAM" no="18">
					<text>In addition, N-terminal AR generated a surface of functional interaction, since its suppression abolished the FHL2 link.</text>
					<arg n="0">N-terminal AR</arg>
					<arg n="1">a surface of functional interaction</arg>
				</example>
				<example src="EGRAM" no="19">
					<text>In addition, the term N-AR generates a functional interaction surface, as its elimination removes the FHL2 link.</text>
					<arg n="0">the term N-AR</arg>
					<arg n="1">a functional interaction surface</arg>
				</example>
				<example src="EGRAM" no="19">
					<text>In addition, the N-term AR generates a functional interaction surface, since its deletion abolishes the FHL2 bond.</text>
					<arg n="0">the N-term AR</arg>
					<arg n="1">a functional interaction surface</arg>
				</example>
				<example src="EGRAM" no="20">
					<text>In addition, the N-term AR, whose deletion abolishes the FHL2 bond, generates a functional interaction surface.</text>
					<arg n="0">the N-term AR</arg>
					<arg n="1">a functional interaction surface</arg>
				</example>
				<example src="EGRAM" no="20">
					<text>In addition, the term N-AR, whose elimination removes the FHL2 link, generates a surface of functional interaction.</text>
					<arg n="0">the term N-AR</arg>
					<arg n="1">a surface of functional interaction</arg>
				</example>
				<example src="EGRAM" no="21">
					<text>In addition, the term N-AR, whose deletion was abolished by FHL2, generated a surface of functional interaction.</text>
					<arg n="0">the term N-AR</arg>
					<arg n="1">a surface of functional interaction</arg>
				</example>
				<example src="EGRAM" no="21">
					<text>In addition, the N-terminal RA, whose suppression had abolished FHL2 binding, generated a surface of functional interaction.</text>
					<arg n="0">the N-terminal RA</arg>
					<arg n="1">a surface of functional interaction</arg>
				</example>
				<example src="EGRAM" no="22">
					<text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of degradation, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
					<arg n="0">degradation</arg>
					<arg n="M-NEG">no</arg>
				</example>
				<example src="EGRAM" no="22">
					<text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of degradation, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
					<arg n="0">degradation</arg>
					<arg n="M-NEG">no</arg>
				</example>
				<example src="EGRAM" no="23">
					<text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of degradation, though again the relatively small fraction involved and the possibility that specific fragments are not generated by degradation.</text>
					<arg n="0">degradation</arg>
					<arg n="1">specific fragments</arg>
					<arg n="M-NEG">not</arg>
				</example>
				<example src="EGRAM" no="23">
					<text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of degradation, but again the relatively small fraction involved and the possibility that specific fragments are no generated by degradation.</text>
					<arg n="0">degradation</arg>
					<arg n="1">specific fragments</arg>
					<arg n="M-NEG">no</arg>
				</example>
				<example src="EGRAM" no="24">
					<text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of degradation, but again the relatively small fraction involved and the possibility that specific fragments has no was generated by degradation.</text>
					<arg n="0">degradation</arg>
					<arg n="1">specific fragments</arg>
					<arg n="M-NEG">no</arg>
				</example>
				<example src="EGRAM" no="24">
					<text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of degradation, though again the relatively small fraction involved and the possibility that specific fragments have not has been generated by degradation.</text>
					<arg n="0">degradation</arg>
					<arg n="1">specific fragments</arg>
					<arg n="M-NEG">not</arg>
				</example>
				<example src="EGRAM" no="25">
					<text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of degradation, though again the relatively small fraction involved and the possibility that specific fragments would be not generated by degradation.</text>
					<arg n="0">degradation</arg>
					<arg n="1">specific fragments</arg>
					<arg n="M-NEG">not</arg>
				</example>
				<example src="EGRAM" no="25">
					<text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of degradation, but again the relatively small fraction involved and the possibility that specific fragments would be no generated by degradation.</text>
					<arg n="0">degradation</arg>
					<arg n="1">specific fragments</arg>
					<arg n="M-NEG">no</arg>
				</example>
				<example src="EGRAM" no="26">
					<text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of degradation, although again the relatively small fraction involved and the possibility that specific fragments is generated by not for degradation.</text>
					<arg n="0">degradation</arg>
					<arg n="1">specific fragments</arg>
					<arg n="M-NEG">not</arg>
				</example>
				<example src="EGRAM" no="26">
					<text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of degradation, although again the relatively small fraction involved and the possibility that specific fragments will be generated by no by degradation.</text>
					<arg n="0">degradation</arg>
					<arg n="1">specific fragments</arg>
					<arg n="M-NEG">no</arg>
				</example>
				<example src="EGRAM" no="27">
					<text>In the absence of L-arginine, nNOS generated superoxide (O(2)-).</text>
					<arg n="0">nNOS</arg>
					<arg n="1">superoxide</arg>
				</example>
				<example src="EGRAM" no="27">
					<text>In the absence of L-arginine, NNOS generated superoxide (O(2)-).</text>
					<arg n="0">NNOS</arg>
					<arg n="1">superoxide</arg>
				</example>
				<example src="EGRAM" no="28">
					<text>In the absence of L-arginine, nNOS generates superoxide (O(2)-).</text>
					<arg n="0">nNOS</arg>
					<arg n="1">superoxide</arg>
				</example>
				<example src="EGRAM" no="28">
					<text>In the absence of L-arginine, NNOS generates superoxide (O(2)-).</text>
					<arg n="0">NNOS</arg>
					<arg n="1">superoxide</arg>
				</example>
				<example src="EGRAM" no="29">
					<text>In the absence of L-arginine, suspected (O(2)-) was generated by nNOS.</text>
					<arg n="0">nNOS</arg>
					<arg n="1">suspected</arg>
				</example>
				<example src="EGRAM" no="29">
					<text>In the absence of L-arginine, superoxide (O(2)-) has been generated by nNOS.</text>
					<arg n="0">nNOS</arg>
					<arg n="1">superoxide</arg>
				</example>
				<example src="EGRAM" no="30">
					<text>In the absence of L-arginine, superoxide (O(2)-) is generated by nNOS.</text>
					<arg n="0">nNOS</arg>
					<arg n="1">superoxide</arg>
				</example>
				<example src="EGRAM" no="30">
					<text>In the absence of L-arginine, suspected (O(2)-) is generated by nNOS.</text>
					<arg n="0">nNOS</arg>
					<arg n="1">suspected</arg>
				</example>
				<example src="EGRAM" no="31">
					<text>In the absence of L-arginine, superoxide (O(2)-) was generated by nNOS.</text>
					<arg n="0">nNOS</arg>
					<arg n="1">superoxide</arg>
				</example>
				<example src="EGRAM" no="31">
					<text>In the absence of L-arginine, superoxide (O(2)-) was generated by NNOS.</text>
					<arg n="0">NNOS</arg>
					<arg n="1">superoxide</arg>
				</example>
				<example src="EGRAM" no="32">
					<text>In the absence of L-arginine, superoxide (O(2)-) will be generated by nNOS.</text>
					<arg n="0">nNOS</arg>
					<arg n="1">superoxide</arg>
				</example>
				<example src="EGRAM" no="32">
					<text>In the absence of L-arginine, superoxide (O(2)-) will be generated by NNOS.</text>
					<arg n="0">NNOS</arg>
					<arg n="1">superoxide</arg>
				</example>
				<example src="EGRAM" no="33">
					<text>main transcripts of 1.7 and 2.7 kb is generated by PRnd.</text>
					<arg n="0">PRnd</arg>
					<arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
				</example>
				<example src="EGRAM" no="33">
					<text>main transcripts of 1.7 and 2.7 kb are generated by PRnd.</text>
					<arg n="0">PRnd</arg>
					<arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
				</example>
				<example src="EGRAM" no="34">
					<text>main transcripts of 1.7 and 2.7 kb was generated by PRnd.</text>
					<arg n="0">PRnd</arg>
					<arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
				</example>
				<example src="EGRAM" no="34">
					<text>main transcripts of 1.7 and 2.7 kb were generated by PRnd.</text>
					<arg n="0">PRnd</arg>
					<arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
				</example>
				<example src="EGRAM" no="35">
					<text>NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
					<arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
					<arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
				</example>
				<example src="EGRAM" no="35">
					<text>None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
					<arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
					<arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
				</example>
				<example src="EGRAM" no="36">
					<text>NONE reacts anaerobically with the purified FNR group FNR generated spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
					<arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
					<arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
				</example>
				<example src="EGRAM" no="36">
					<text>does not react anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
					<arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
					<arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
				</example>
				<example src="EGRAM" no="37">
					<text>prnd can generate main transcripts of 1.7 and 2.7 kb.</text>
					<arg n="0">prnd</arg>
					<arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
				</example>
				<example src="EGRAM" no="37">
					<text>prnd can generate main transcripts of 1.7 and 2.7 kb.</text>
					<arg n="0">prnd</arg>
					<arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
				</example>
				<example src="EGRAM" no="38">
					<text> Prnd generated main transcripts of 1.7 and 2.7 kb.</text>
					<arg n="0"> Prnd</arg>
					<arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
				</example>
				<example src="EGRAM" no="38">
					<text>Prnd generated main transcripts of 1.7 and 2.7 kb.</text>
					<arg n="0">Prnd</arg>
					<arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
				</example>
				<example src="EGRAM" no="39">
					<text>prnd generates main transcripts of 1.7 and 2.7 kb.</text>
					<arg n="0">prnd</arg>
					<arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
				</example>
				<example src="EGRAM" no="39">
					<text>prnd generates main transcripts of 1.7 and 2.7 kb.</text>
					<arg n="0">prnd</arg>
					<arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
				</example>
				<example src="EGRAM" no="40">
					<text>prnd is able to generate main transcripts of 1.7 and 2.7 kb.</text>
					<arg n="0">prnd</arg>
					<arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
				</example>
				<example src="EGRAM" no="40">
					<text>Prnd is able to generate large transcriptions of 1.7 and 2.7 kb .</text>
					<arg n="0">Prnd</arg>
					<arg n="1">large transcriptions of 1.7 and 2.7 kb </arg>
				</example>
				<example src="EGRAM" no="41">
					<text>overlapping sequential fragments are generated by the TBC method (approximately 0.4&#8211;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
					<arg n="0">the TBC method</arg>
					<arg n="1">overlapping sequential fragments</arg>
				</example>
				<example src="EGRAM" no="41">
					<text>A1 is generated by CTB method (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
					<arg n="0">CTB method</arg>
				</example>
				<example src="EGRAM" no="42">
					<text>sequential overlapping fragments was generated by TBC method (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
					<arg n="0">TBC method</arg>
					<arg n="1">sequential overlapping fragments</arg>
				</example>
				<example src="EGRAM" no="42">
					<text>overlapping sequential fragments were generated by the TBC method (approximately 0.4&#8211;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
					<arg n="0">the TBC method</arg>
					<arg n="1">overlapping sequential fragments</arg>
				</example>
				<example src="EGRAM" no="43">
					<text>The Stat5aEE-AA of Stat5a was generated by A0 (muting amino acids EE (437 and 438) for AA. The FLAAG epitope was added to the Stat5aEE-AA terminal C.</text>
					<arg n="1">Stat5aEE-AA</arg>
				</example>
				<example src="EGRAM" no="43">
					<text>The Stat5aEE-AA of Stat5a has been generated by muting amino acids EE (437 and 438) to AA .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
					<arg n="0">muting amino acids EE (437 and 438) to AA </arg>
					<arg n="1">Stat5aEE-AA</arg>
				</example>
				<example src="EGRAM" no="44">
					<text>The Stat5aEE-AA of Stat5a is generated by A0 (muting amino acids EE (437 and 438) for AA.</text>
					<arg n="1">Stat5aEE-AA</arg>
				</example>
				<example src="EGRAM" no="44">
					<text>Stat5aEE-AA DNA-binding mutant is generated by EE amino acids (437 and 438) for AA. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
					<arg n="0">EE amino acids (437 and 438) for AA</arg>
					<arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
				</example>
				<example src="EGRAM" no="45">
					<text>Stat5aEE-AA DNA-binding mutant will be generated by mino EE mutant acids (437 and 438) for AA. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
					<arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
					<arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
				</example>
				<example src="EGRAM" no="45">
					<text>The Stat5aEE-AA of Stat5a will be generated by muting amino acids EE (437 and 438) to AA.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
					<arg n="0">muting amino acids EE (437 and 438) to AA</arg>
					<arg n="1">Stat5aEE-AA</arg>
				</example>
				<example src="EGRAM" no="46">
					<text>TBC method generated overlapping sequential fragments (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
					<arg n="0">TBC method</arg>
					<arg n="1">overlapping sequential fragments</arg>
				</example>
				<example src="EGRAM" no="46">
					<text>TBC method generated sequential overlapping fragments (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
					<arg n="0">TBC method</arg>
					<arg n="1">sequential overlapping fragments</arg>
				</example>
				<example src="EGRAM" no="47">
					<text>TBC method generates sequential overlapping fragments (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
					<arg n="0">TBC method</arg>
					<arg n="1">sequential overlapping fragments</arg>
				</example>
				<example src="EGRAM" no="47">
					<text>the TBC method generates overlapping sequential fragments (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
					<arg n="0">the TBC method</arg>
					<arg n="1">overlapping sequential fragments</arg>
				</example>
				<example src="EGRAM" no="48">
					<text>TBC method generated sequential fragment overlapping for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
					<arg n="0">TBC method</arg>
					<arg n="1">sequential fragment overlapping</arg>
				</example>
				<example src="EGRAM" no="48">
					<text>the TBC method has generated overlapping sequential fragments for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
					<arg n="0">the TBC method</arg>
					<arg n="1">overlapping sequential fragments</arg>
				</example>
				<example src="EGRAM" no="49">
					<text>TBC method can generate sequential superposition fragments (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
					<arg n="0">TBC method</arg>
					<arg n="1">sequential superposition fragments</arg>
				</example>
				<example src="EGRAM" no="49">
					<text>the TBC method can generate superposed sequential defects (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
					<arg n="0">the TBC method</arg>
					<arg n="1">superposed sequential defects</arg>
				</example>
				<example src="EGRAM" no="50">
					<text>The biceps RNase III Dicer generated the 21-23 nt of long mature RNAs.</text>
					<arg n="0">biceps RNase III Dicer</arg>
					<arg n="1">21-23 nt of long mature RNAs</arg>
				</example>
				<example src="EGRAM" no="50">
					<text>The biceps RNase III Dicer generated the 21-23 nt of long mature RNAs.</text>
					<arg n="0">The biceps RNase III Dicer</arg>
					<arg n="1">the 21-23 nt of long mature RNAs</arg>
				</example>
				<example src="EGRAM" no="51">
					<text>The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs.</text>
					<arg n="0">biceps RNase III Dicer</arg>
					<arg n="1">21-23 nt of long mature RNAs</arg>
				</example>
				<example src="EGRAM" no="51">
					<text>The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs.</text>
					<arg n="0">The biceps RNase III Dicer</arg>
					<arg n="1">the 21-23 nt of long mature RNAs</arg>
				</example>
				<example src="EGRAM" no="52">
					<text>The biceps RNase III Dicer generated the 21-23 nt of long mature RNAs.</text>
					<arg n="0">The biceps RNase III Dicer</arg>
					<arg n="1">the 21-23 nt of long mature RNAs</arg>
				</example>
				<example src="EGRAM" no="52">
					<text>The biceps RNase III Dicer generated the 21-23 nt of long mature RNAs.</text>
					<arg n="0">biceps RNase III Dicer</arg>
					<arg n="1">21-23 nt of long mature RNAs</arg>
				</example>
				<example src="EGRAM" no="53">
					<text>bidentate RNase III is able to generate mature RNA 21-23 nt.</text>
					<arg n="0">bidentate RNase III</arg>
					<arg n="1">mature RNA 21-23 nt</arg>
				</example>
				<example src="EGRAM" no="53">
					<text>The biceps RNase III Dicer is able to generate long mature RNAs of 21-23 nt .</text>
					<arg n="0">The biceps RNase III Dicer</arg>
					<arg n="1">long mature RNAs of 21-23 nt </arg>
				</example>
				<example src="EGRAM" no="54">
					<text>These are smoke reductase (coded by the operon of frdABCD), smoke B, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
					<arg n="0">smoke B</arg>
					<arg n="1">smoke</arg>
				</example>
				<example src="EGRAM" no="54">
					<text>These are fumat reductase (encoded by the operon frdABCD), fumat B, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
					<arg n="0">fumat B</arg>
					<arg n="1">fumat</arg>
				</example>
				<example src="EGRAM" no="55">
					<text>These are smoke reductase (coded by the operon of frdABCD), smoke B, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
					<arg n="0">smoke B</arg>
					<arg n="1">smoke</arg>
				</example>
				<example src="EGRAM" no="55">
					<text>These are fumat reductase (encoded by the operon frdABCD), fumat B, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
					<arg n="0">fumat B</arg>
					<arg n="1">fumat</arg>
				</example>
				<example src="EGRAM" no="56">
					<text>These are fumat reductase (encoded by the operon frdABCD), fumatase B, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
					<arg n="0">fumatase B</arg>
					<arg n="1">fumat</arg>
				</example>
				<example src="EGRAM" no="56">
					<text>These are smoke reductase (coded by the operon of frdABCD), smoke B, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
					<arg n="0">smoke B</arg>
					<arg n="1">smoke</arg>
				</example>
				<example src="EGRAM" no="57">
					<text>To specifically analyze the protein expression of FHL2 in human tissues, nodes may generate monoclonal antibody against FHL2.</text>
					<arg n="0">nodes</arg>
					<arg n="1">monoclonal antibody against FHL2</arg>
				</example>
				<example src="EGRAM" no="57">
					<text>To specifically analyze the protein expression of FHL2 in human tissues ens can generate a monoclonal antibody vs. FHL2.</text>
					<arg n="0">ens</arg>
					<arg n="1">a monoclonal antibody vs. FHL2</arg>
				</example>
				<example src="EGRAM" no="58">
					<text>To specifically analyse the protein expression of FHL2 in human tissue, monoclonal antibody vs. FHL2 is generated by us.</text>
					<arg n="0">us</arg>
					<arg n="1">monoclonal antibody vs. FHL2</arg>
				</example>
				<example src="EGRAM" no="58">
					<text>To specifically analyse the protein expression of FHL2 in human tissues, monoclonal antibody against FHL2 is generated by us.</text>
					<arg n="0">us</arg>
					<arg n="1">monoclonal antibody against FHL2</arg>
				</example>
				<example src="EGRAM" no="59">
					<text>To specifically analyze the protein expression of FHL2 in human tissue, monoclonal antibody vs. FHL2 was generated by us.</text>
					<arg n="0">us</arg>
					<arg n="1">monoclonal antibody vs. FHL2</arg>
				</example>
				<example src="EGRAM" no="59">
					<text>To specifically analyze the protein expression of FHL2 in human tissues, monoclonal antibody against FHL2 was generated by us.</text>
					<arg n="0">us</arg>
					<arg n="1">monoclonal antibody against FHL2</arg>
				</example>
				<example src="EGRAM" no="60">
					<text>To specifically analyze the protein expression of FHL2 in human tissues, nodes generates monoclonal antibody against FHL2 .</text>
					<arg n="0">nodes</arg>
					<arg n="1">monoclonal antibody against FHL2 </arg>
				</example>
				<example src="EGRAM" no="60">
					<text>To specifically analyse the protein expression of FHL2 in human tissues, ens generates a monoclonal antibody vs. FHL2.</text>
					<arg n="0">ens</arg>
					<arg n="1">a monoclonal antibody vs. FHL2</arg>
				</example>
				<example src="EGRAM" no="61">
					<text>To specifically analyse the protein expression of FHL2 in human tissues, nodes will generate monoclonal antibody vs. FHL2.</text>
					<arg n="0">nodes</arg>
					<arg n="1">monoclonal antibody vs. FHL2</arg>
				</example>
				<example src="EGRAM" no="61">
					<text>To specifically analyze the protein expression of FHL2 in human tissues, nodes will generate monoclonal antibody against FHL2.</text>
					<arg n="0">nodes</arg>
					<arg n="1">monoclonal antibody against FHL2</arg>
				</example>
				<example src="EGRAM" no="62">
					<text>We believe that this union is able to generate a higher-order protein-DNA complex within the reombian synapses.</text>
					<arg n="0">this union</arg>
					<arg n="1">a higher-order protein-DNA complex</arg>
				</example>
				<example src="EGRAM" no="62">
					<text>We believe that this binding is able to generate a higher order DNA-protein complex within the recombinant synapse.</text>
					<arg n="0">this binding</arg>
					<arg n="1">a higher order DNA-protein complex</arg>
				</example>
				<example src="EGRAM" no="63">
					<text>We believe that this union is shown to generate a higher-order protein&#8211;DNA complex within the reombine synapses.</text>
					<arg n="0">this union</arg>
					<arg n="1">a higher-order protein&#8211;DNA complex</arg>
				</example>
				<example src="EGRAM" no="63">
					<text>We believe that this union is able to generate high-order protein-DNA complex within the reombian synapses.</text>
					<arg n="0">this union</arg>
					<arg n="1">high-order protein-DNA complex</arg>
				</example>
				<example src="EGRAM" no="64">
					<text>We report results of previous transcription experiments of microarrays that revealed two previously unknown members of NarL regulation: the aspA gene coding aspartate-amonylliase being able to generate furama; and the operon dcuSR coding the regulatory system responsive to dicarboxylate.</text>
					<arg n="0">aspartate-amonylliase</arg>
					<arg n="1">furama</arg>
				</example>
				<example src="EGRAM" no="64">
					<text>We report the results of previous transcription experiments of microarrays that revealed two previously unknown members of the NarL regulator: the aspA gene that codes aspartate-amon lysase that is able to generate fumat; and operon dcuSR that codes the dicarboxylate response regulation system.</text>
					<arg n="0">aspartate-amon lysase</arg>
					<arg n="1">fumat</arg>
				</example>
				<example src="EGRAM" no="65">
					<text>We report the results of previous transcription experiments of microarrays that revealed two previously unknown members of the NarL regulator: the aspA gene coding aspartate-amon lilase that generating fumat; and the operon dcuSR coding the dicarboxylate response regulation system.</text>
					<arg n="0">aspartate-amon lilase</arg>
					<arg n="1">fumat</arg>
				</example>
				<example src="EGRAM" no="65">
					<text>We report the results of preliminary transcription microarray experiments that revealed two previously unknown members of the NarL regulator: the aspA gene encoding aspartate-ammonia lyase that generating fumat ; and the dcuSR operon encoding the dicarboxylate response regulatory system.</text>
					<arg n="0">aspartate-ammonia lyase</arg>
					<arg n="1">fumat </arg>
				</example>
				<example src="EGRAM" no="66">
					<text>We report the results of preliminary transcription microarray experiments that revealed two previously unknown members of the NarL regulator: the aspA gene encoding aspartate-ammonia lyase that generates fumat ; and the dcuSR operon encoding the dicarboxylate response regulatory system.</text>
					<arg n="0">aspartate-ammonia lyase</arg>
					<arg n="1">fumat </arg>
				</example>
				<example src="EGRAM" no="66">
					<text>We report the results of earlier microarrays transcription experiments that revealed two previously unknown members of the NarL regulation: the aspA gene encoding aspartate-amon system that generates sondes; and the dcuSR operon encoding the responsive regulatory system in dicarboxylate.</text>
					<arg n="0">aspartate-amon system</arg>
					<arg n="1">sondes</arg>
				</example>
				<example src="EGRAM" no="67">
					<text>We report the results of preliminary transcription microarray experiments that revealed two previously unknown members of the NarL regulator: the aspA gene encoding aspartate-ammonia lyase that generated fumat ; and the dcuSR operon encoding the dicarboxylate response regulatory system.</text>
					<arg n="0">aspartate-ammonia lyase</arg>
					<arg n="1">fumat </arg>
				</example>
				<example src="EGRAM" no="67">
					<text>We reported the results of earlier microarrays transcription experiments that revealed two previously unknown members of the NarL regulation: the aspA gene encoding aspartate-amon lysis that generated furama and the dcuSR operon encoding the dicarboxylate-responsive regulatory system.</text>
					<arg n="0">aspartate-amon lysis</arg>
					<arg n="1">furama</arg>
				</example>
				<example src="EGRAM" no="68">
					<text>a hypersensitive to DNase I is generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
					<arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
					<arg n="1">a hypersensitive to DNase I</arg>
				</example>
				<example src="EGRAM" no="68">
					<text>a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
					<arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
					<arg n="1">a hypersensitive to DNase I</arg>
				</example>
				<example src="EGRAM" no="69">
					<text>hypersensitive to DNase I was generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
					<arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
					<arg n="1">hypersensitive to DNase I</arg>
				</example>
				<example src="EGRAM" no="69">
					<text>a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
					<arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
					<arg n="1">a hypersensitive to DNase I</arg>
				</example>
				<example src="EGRAM" no="70">
					<text>a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1) generates A1 (a DNase I hypersensitivity complex.</text>
					<arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-reactivation complex (E-CR1)</arg>
				</example>
				<example src="EGRAM" no="70">
					<text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive chromatin I remodeling complex.</text>
					<arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
					<arg n="1">a hypersensitive chromatin I remodeling complex</arg>
				</example>
				<example src="EGRAM" no="71">
					<text>a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex generated A1 (a hypersensitive complex with DNase I.</text>
					<arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex</arg>
				</example>
				<example src="EGRAM" no="71">
					<text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive DNase I.</text>
					<arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
					<arg n="1">a hypersensitive DNase I</arg>
				</example>
				<example src="EGRAM" no="72">
					<text>a functional interaction surface is generated by the N-terminal RA whose deletion removes the FHL2 binding.</text>
					<arg n="0">the N-terminal RA</arg>
					<arg n="1">a functional interaction surface</arg>
				</example>
				<example src="EGRAM" no="72">
					<text>a functional interaction surface is generated by the N-terminal AR whose elimination removes the FHL2 link.</text>
					<arg n="0">the N-terminal AR</arg>
					<arg n="1">a functional interaction surface</arg>
				</example>
				<example src="EGRAM" no="73">
					<text>a functional interaction surface was generated by the N-terminal RA, because the N-terminal RAs eliminates FHL2.</text>
					<arg n="0">the N-terminal RA</arg>
					<arg n="1">a functional interaction surface</arg>
				</example>
				<example src="EGRAM" no="73">
					<text>a surface of functional interaction was generated by N-terminus AR, as the elimination of N-terminus AR eliminated the FHL2 link.</text>
					<arg n="0">N-terminus AR</arg>
					<arg n="1">a surface of functional interaction</arg>
				</example>
				<example src="EGRAM" no="74">
					<text>a higher DNA complex is generated by this binding within the recombinant synapses.</text>
					<arg n="0">this binding</arg>
					<arg n="1">a higher DNA complex</arg>
				</example>
				<example src="EGRAM" no="74">
					<text>a higher DNA-protein complex is generated by this binding within the recombinant synapse.</text>
					<arg n="0">this binding</arg>
					<arg n="1">a higher DNA-protein complex</arg>
				</example>
				<example src="EGRAM" no="75">
					<text>high-order DNA-protein complex was generated by this binding within the recombinant synapse.</text>
					<arg n="0">this binding</arg>
					<arg n="1">high-order DNA-protein complex</arg>
				</example>
				<example src="EGRAM" no="75">
					<text>high-order DNA protein complex was generated by this binding within the recombinant synapse.</text>
					<arg n="0">this binding</arg>
					<arg n="1">high-order DNA protein complex</arg>
				</example>
				<example src="EGRAM" no="76">
					<text>an alternative splicing of primary genetic transcription generated HLA-G molecules of antigen human leukocytes.</text>
					<arg n="0">an alternative splicing of primary genetic transcription</arg>
					<arg n="1">HLA</arg>
				</example>
				<example src="EGRAM" no="76">
					<text>an alternative coupling of the primary transcription of the gene generated HLA-G molecules of human leukocytes.</text>
					<arg n="0">an alternative coupling of the primary transcription of the gene</arg>
					<arg n="1">HLA</arg>
				</example>
				<example src="EGRAM" no="77">
					<text>an alternative coupling of primary genetic transcription generates HLA-G molecules of antigen human leukocytes.</text>
					<arg n="0">an alternative coupling of primary genetic transcription</arg>
					<arg n="1">HLA</arg>
				</example>
				<example src="EGRAM" no="77">
					<text>an alternative coupling of the primary transcription of the gene generates HLA-G molecules of human leukocytes.</text>
					<arg n="0">an alternative coupling of the primary transcription of the gene</arg>
					<arg n="1">HLA</arg>
				</example>
				<example src="EGRAM" no="78">
					<text>moker (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by smoker B.</text>
					<arg n="0">smoker B</arg>
					<arg n="1">moker</arg>
				</example>
				<example src="EGRAM" no="78">
					<text>smoker (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by smoker B.</text>
					<arg n="0">smoker B</arg>
					<arg n="1">smoker</arg>
				</example>
				<example src="EGRAM" no="79">
					<text>motor (carot, and permease from DcuB to motor, carot and aspartate) were generated by smoker B.</text>
					<arg n="0">smoker B</arg>
					<arg n="1">motor</arg>
				</example>
				<example src="EGRAM" no="79">
					<text>smoker (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by smoker B.</text>
					<arg n="0">smoker B</arg>
					<arg n="1">smoker</arg>
				</example>
				<example src="EGRAM" no="80">
					<text>intergenic splicing with Prnp generates some unusual symmetric transcriptions.</text>
					<arg n="0">intergenic splicing with Prnp</arg>
					<arg n="1">some unusual symmetric transcriptions</arg>
				</example>
				<example src="EGRAM" no="80">
					<text>intergenic slicing with Prnp generates some unusual chemical transcriptions.</text>
					<arg n="0">intergenic slicing with Prnp</arg>
					<arg n="1">some unusual chemical transcriptions</arg>
				</example>
				<example src="EGRAM" no="81">
					<text>intergenic slicing with Prnp generated some unusual symmetrical transcriptions.</text>
					<arg n="0">intergenic slicing with Prnp</arg>
					<arg n="1">some unusual symmetrical transcriptions</arg>
				</example>
				<example src="EGRAM" no="81">
					<text>intergenic splicing with Prnp has generated some unusual symmetric transcriptions.</text>
					<arg n="0">intergenic splicing with Prnp</arg>
					<arg n="1">some unusual symmetric transcriptions</arg>
				</example>
				<example src="EGRAM" no="82">
					<text>Minoan mutants EE (437 and 438) in AA are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
					<arg n="0">Minoan mutants EE (437 and 438) in AA</arg>
				</example>
				<example src="EGRAM" no="82">
					<text>mino mutant acids EE (437 and 438) to AA are able to generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a .</text>
					<arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
					<arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a </arg>
				</example>
				<example src="EGRAM" no="83">
					<text>Mino-EE mutant acids (437 and 438) in AA can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
					<arg n="0">Mino-EE mutant acids (437 and 438) in AA</arg>
				</example>
				<example src="EGRAM" no="83">
					<text>muting amino acids EE (437 and 438) to AA can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
					<arg n="0">muting amino acids EE (437 and 438) to AA</arg>
				</example>
				<example src="EGRAM" no="84">
					<text>mino acid mutants EE (437 and 438) in AA generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
					<arg n="0">mino acid mutants EE (437 and 438) in AA</arg>
				</example>
				<example src="EGRAM" no="84">
					<text>mino mutant acids EE (437 and 438) to AA generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
					<arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
				</example>
				<example src="EGRAM" no="85">
					<text>mino acid mutants EE (437 and 438) in AA generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
					<arg n="0">mino acid mutants EE (437 and 438) in AA</arg>
				</example>
				<example src="EGRAM" no="85">
					<text>mino mutant acids EE (437 and 438) to AA generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
					<arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
				</example>
				<example src="EGRAM" no="86">
					<text>proteolysis of amyloid precursor proteins (APP) generates Abeta peptides.</text>
					<arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
					<arg n="1">Abeta peptides</arg>
				</example>
				<example src="EGRAM" no="86">
					<text>proteolysis of amyloid precursor proteins generates Abeta peptides.</text>
					<arg n="0">proteolysis of amyloid precursor proteins</arg>
					<arg n="1">Abeta peptides</arg>
				</example>
				<example src="EGRAM" no="87">
					<text>proteolysis of amyloid precursor proteins (APP) generated Abeta peptides.</text>
					<arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
					<arg n="1">Abeta peptides</arg>
				</example>
				<example src="EGRAM" no="87">
					<text>generatedpgeneratedrgeneratedogeneratedtgeneratedegeneratedogeneratedlgeneratedygeneratedsgeneratedigeneratedsgenerated generatedogeneratedfgenerated generatedageneratedmgeneratedygeneratedlgeneratedogeneratedigenerateddgenerated generatedpgeneratedrgeneratedegeneratedcgeneratedugeneratedrgeneratedsgeneratedogeneratedrgenerated generatedpgeneratedrgeneratedogeneratedtgeneratedegeneratedigeneratedngeneratedsgenerated generated(generatedAgeneratedPgeneratedPgenerated)generated generatedggeneratedegeneratedngeneratedegeneratedrgeneratedageneratedtgeneratedegenerateddgenerated generatedageneratedbgeneratedegeneratedtgeneratedagenerated generatedpgeneratedegeneratedpgeneratedtgeneratedigenerateddgeneratedegeneratedsgenerated.generated</text>
					<arg n="0">proteolysis of amyloid precursor proteins (APP) generated A1 (abeta peptides)</arg>
					<arg n="1">abeta peptides</arg>
				</example>
				<example src="EGRAM" no="88">
					<text>some unusual chemical transcriptions is generated by intergenic spike with Prnp.</text>
					<arg n="0">intergenic spike with Prnp</arg>
					<arg n="1">some unusual chemical transcriptions</arg>
				</example>
				<example src="EGRAM" no="88">
					<text>some unusual chemeric transcriptions are generated by intergenic splicing with Prnp.</text>
					<arg n="0">intergenic splicing with Prnp</arg>
					<arg n="1">some unusual chemeric transcriptions</arg>
				</example>
				<example src="EGRAM" no="89">
					<text>some unusual chemical transcriptions was generated by intergenic spike with Prnp.</text>
					<arg n="0">intergenic spike with Prnp</arg>
					<arg n="1">some unusual chemical transcriptions</arg>
				</example>
				<example src="EGRAM" no="89">
					<text>some unusual chemeric transcriptions have been generated by intergenic splicing with Prnp.</text>
					<arg n="0">intergenic splicing with Prnp</arg>
					<arg n="1">some unusual chemeric transcriptions</arg>
				</example>
				<example src="EGRAM" no="90">
					<text>some unusual chimeric transcriptions can be generated by intergenic slicing with Prnp.</text>
					<arg n="0">intergenic slicing with Prnp</arg>
					<arg n="1">some unusual chimeric transcriptions</arg>
				</example>
				<example src="EGRAM" no="90">
					<text>some unusual chemical transcriptions can be generated by intergenic spike with Prnp.</text>
					<arg n="0">intergenic spike with Prnp</arg>
					<arg n="1">some unusual chemical transcriptions</arg>
				</example>
				<example src="EGRAM" no="91">
					<text>some unusual chemical transcriptions was generated by intergenic spike with Prnp.</text>
					<arg n="0">intergenic spike with Prnp</arg>
					<arg n="1">some unusual chemical transcriptions</arg>
				</example>
				<example src="EGRAM" no="91">
					<text>some unusual chemeric transcriptions were generated by intergenic splicing with Prnp.</text>
					<arg n="0">intergenic splicing with Prnp</arg>
					<arg n="1">some unusual chemeric transcriptions</arg>
				</example>
				<example src="EGRAM" no="92">
					<text>some unusual chimeric transcriptions will be generated by intergenic slicing with Prnp.</text>
					<arg n="0">intergenic slicing with Prnp</arg>
					<arg n="1">some unusual chimeric transcriptions</arg>
				</example>
				<example src="EGRAM" no="92">
					<text>some unusual chemical transcriptions will be generated by intergenic spike with Prnp.</text>
					<arg n="0">intergenic spike with Prnp</arg>
					<arg n="1">some unusual chemical transcriptions</arg>
				</example>
				<example src="EGRAM" no="93">
					<text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex are generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
					<arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
					<arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
				</example>
				<example src="EGRAM" no="93">
					<text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex are generated by none reacts anaerobically with the purified F-S group of FNR.</text>
					<arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
					<arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
				</example>
				<example src="EGRAM" no="94">
					<text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex was generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
					<arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
					<arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
				</example>
				<example src="EGRAM" no="94">
					<text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex were generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
					<arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
					<arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
				</example>
				<example src="EGRAM" no="95">
					<text>mature RNA 21-23 nt is generated by the bidentate RNase III Dicer.</text>
					<arg n="0">the bidentate RNase III Dicer</arg>
					<arg n="1">mature RNA 21-23 nt</arg>
				</example>
				<example src="EGRAM" no="95">
					<text>long RNAs of 21-23 nt are generated by The biceps RNase III Dicer .</text>
					<arg n="0">The biceps RNase III Dicer </arg>
					<arg n="1">long RNAs of 21-23 nt</arg>
				</example>
				<example src="EGRAM" no="96">
					<text>mature RNA 21-23 nt was generated by bidentate RNase III.</text>
					<arg n="0">bidentate RNase III</arg>
					<arg n="1">mature RNA 21-23 nt</arg>
				</example>
				<example src="EGRAM" no="96">
					<text>long RNAs of 21-23 nt were generated by Bydented RNase III dyce.</text>
					<arg n="0">Bydented RNase III dyce</arg>
					<arg n="1">long RNAs of 21-23 nt</arg>
				</example>
				<example src="EGRAM" no="97">
					<text>this binding generated a high-order DNA-protein complex within the recombinant synapse.</text>
					<arg n="0">this binding</arg>
					<arg n="1">a high-order DNA-protein complex</arg>
				</example>
				<example src="EGRAM" no="97">
					<text>A0 generated a high-order protein DNA complex within the recombinant synapses.</text>
					<arg n="1">a high-order protein DNA complex</arg>
				</example>
				<example src="EGRAM" no="98">
					<text>this junction generates a higher-order protein DNA complex within the recombinant synapses.</text>
					<arg n="0">this junction</arg>
					<arg n="1">a higher-order protein DNA complex</arg>
				</example>
				<example src="EGRAM" no="98">
					<text>this binding generates a higher order DNA-protein complex within the recombinant synapse.</text>
					<arg n="0">this binding</arg>
					<arg n="1">a higher order DNA-protein complex</arg>
				</example>
			</roleset>
        </predicate>
    </framesest>
</PASBIO>